Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Knowledge Intensive Services

    Knowledge Intensive Services

    Approaching the final frontier: Are we in a golden decade of drug development for the central nervous system?
    13 September 2024

    Approaching the final frontier: Are we in a golden decade of drug development for the central nervous system?

    In this CRA Insights, the authors Will Foster, Kees Chamberlain, Joanne Clark, and Carl Lottig recount the recent scientific and technological advances in drug development in the central nervous system (CNS). CNS disorders impose a significant burden on patients, with the global im...

    Women in corporate setting looking out office building at sunrise with paperwork in hand.
    3 September 2024

    My real-life Cinema Paradiso: how 80s films helped me become a Hollywood interpreter

    One Stop Language Solutions writes: I'm delighted to be back with this month's edition of my newsletter, where I’ll share the story of my career as an interpreter, and how my high school teacher inspired my love of the English language. You'll also get a sneak peek at a new blog I've be...

    Hannah Brynn, Managing Director, Anglia Capital Group
    2 September 2024

    The EpiCentre to host female angel investing seminar and pitching day

    Anglia Capital Group (ACG) is holding a female Angel investing seminar and pitching day at The EpiCentre, near Cambridge, on Friday 27th September 2024, sponsored by the British Business Bank. ...

    Antibody-drug conjugates: where are we now, where is it heading, and how can you get ahead of the opportunities and challenges with key stakeholders?
    21 August 2024

    Antibody-drug conjugates: where are we now, where is it heading, and how can you get ahead of the opportunities and challenges with key stakeholders?

    Antibody-drug conjugates (ADCs) hold great promise for the targeted treatment of cancer, and the market is expected to grow significantly in the upcoming years driven by the continued breakthroughs in ADC technologies. ...

    logo
    27 August 2024

    European Diplomats launches Training Academy offering B2G training courses

    European Diplomats launches the 'European Diplomats Training Academy' in Tallinn, Estonia, offering B2G training courses to equip individuals with essential sales skills aligned with current market trends. ...

    People in audience
    21 August 2024

    Lingang's Role in Global Innovation: A Strategic Partnership Opportunity

    Lingang, situated in southeast Shanghai within the China (Shanghai) Pilot Free Trade Zone, is rapidly emerging as a global leader in innovative technologies. Its strategic location between Pudong International Airport and Yangshan International Port positions it as a vital node in the g...

    Roundtable at IoD. Note: The ambassador has left before the group photo session
    13 August 2024

    Meeting Chinese Ambassador HE Zheng Zeguang: a roundtable on UK/China business growth

    It doesn’t happen every day for the British SMEs to speak directly with China’s top diplomat in the UK. That’s why Crayfish.io joined in to make it happen, a recent roundtable for exactly that purpose, where chief executives of some UK small and medium-sized companies had a conversation...

    31 July 2024

    The end of high drug prices? Exploring the potential and limits of PDABs

    Certain states in the US have enacted or are actively considering legislation to create PDABs, Prescription Drug Affordability Boards. PDABs are independent state bodies comprised of experts in healthcare and economics, empowered to analyze drug costs and suggest ways to lower stat...

    9 July 2024

    Ethics of artificial intelligence in the life sciences industry

    This podcast is part of the Life Sciences 2030 initiative that explores ethics of artificial intelligence (AI) in the life sciences industry. Moderated by Kristen Backor with panelists Michelle Guo, Travis Ruch, and Artes Haderi, the discussion highlights AI’s potential to revolutionize...

    30 July 2024

    EnterpriseWOMEN - going beyond conventions in business model innovation

    From researcher to founder: increasing the number of women founders through hands-on, practical learning experiences. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 42
    • Page 43
    • Current page 44
    • Page 45
    • Page 46
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS